Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Expands By 116.3%

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a large increase in short interest during the month of April. As of April 30th, there was short interest totaling 770 shares, an increase of 116.3% from the April 15th total of 356 shares. Based on an average daily volume of 5,950 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are short sold.

Institutional Trading of Fidelity Disruptive Medicine ETF

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Glass Jacobson Investment Advisors llc raised its stake in Fidelity Disruptive Medicine ETF by 44.0% during the 4th quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after acquiring an additional 385 shares during the last quarter. Jane Street Group LLC raised its stake in Fidelity Disruptive Medicine ETF by 0.8% during the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after acquiring an additional 499 shares during the last quarter. Virtu Financial LLC purchased a new stake in Fidelity Disruptive Medicine ETF during the 4th quarter valued at approximately $228,000. Vise Technologies Inc. purchased a new position in Fidelity Disruptive Medicine ETF during the 4th quarter worth $234,000. Finally, BXM Wealth LLC purchased a new position in Fidelity Disruptive Medicine ETF during the 4th quarter worth $243,000.

Fidelity Disruptive Medicine ETF Trading Down 2.6%

FMED stock traded down $0.64 on Friday, hitting $24.06. The company’s stock had a trading volume of 7,430 shares, compared to its average volume of 13,563. The firm has a 50 day moving average of $24.86 and a two-hundred day moving average of $26.27. The stock has a market cap of $55.34 million, a price-to-earnings ratio of 41.33 and a beta of 0.84. Fidelity Disruptive Medicine ETF has a 1 year low of $22.80 and a 1 year high of $29.07.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.